Powered by RyboCypher™, its proprietary AI-assisted proteogenomics platform, RyboDyn introduces proteins science didn’t know existed—and reveals cYBX1, a cryptic isoform of the well-known cancer driver YBX1. SAN DIEGO, Aug. 12, 2026 /PRNewswire/ — RyboDyn, Inc. today released a preprint…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
